Tardive Dyskinesia Drugs Market Industrial Progress 2018 To 2026 With Key Players Valeant Pharmaceuticals, Neurocrine Biosciences, and Teva Pharmaceutical Industries

Tardive dyskinesia (TD) is a form of dyskinesia that is difficult to treat. It is a nerve disorder characterized by involuntary movements such as jaw, lips, and tongue, considered as grimacing, sticking the tongue out, and lip smacking. Some other symptoms are an individual experiencing involuntary movement of the lower and upper extremities and also breathing choking. According to Center for Drug Evaluation and Research, tardive dyskinesia can lead to disability and can further stigmatize patients with mental illness. Tardive akathisia, a type of tardive dyskinesia, involves acute pain, inner tension, anxiety, and a compulsive drive to move the body.

Download PDF Brochure of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/218

Tardive dyskinesia usually occurs in patients who are under prolong administration of antipsychotic drugs for any neurological disorder such as depression, psychosis, and certain drugs to treat gastrointestinal disorders. In spite of various studies conducted by pharmaceutical companies to know the exact treatment mechanism for tardive dyskinesia, only one drug developed by Neurocrine Biosciences that has received approval. Strong pipeline drugs for treatment of TD disorder are expected to propel growth of the tardive dyskinesia drugs market.

Increasing incidence of neurological disorders to drive growth the Tardive Dyskinesia Drugs Market

According to Mental Health America, the occurrence of tardive dyskinesia is estimated to be 10 to 20% of patients who are earlier treated with long term anti-psychotic medications. According to Neurocrine’s Chief Medical Officer, Chris O’Brien, all doctors and psychiatrists now accept Tardive dyskinesia as a prevalent condition. However, according to Neurocrine Bioscience, there are still an estimated 500,000 people in the U.S., who are affected by Tardive Dyskinesia each year. Lack of awareness on TD and its medication can hinder growth of global tardive dyskinesia drugs market.

Valbenazine to gain the major market share in TD Drugs Market globally

The global tardive dyskinesia drugs market is segmented on the basis of the sub-types, drugs, end user, and geography. On the basis of sub-type, the global market is divided into choreoathetosis, tardive dystonia, blepharospasm, and tardive akathisia. On the basis of drugs, the Global Market is divided into Valbenazine, Tetrabenazine, and others (deutetrabenazine and VMAT2 inhibitor). On the basis of end user, the global market is divided into hospitals, pharmacies, drug stores, and e-commerce.

Strong clinical trial pipeline to treat Tardive Dyskinesia is expected to boost the market for Tardive Dyskinesia Drugs Market in near future

Key players operating in the tardive dyskinesia market include Valeant Pharmaceuticals, Neurocrine Biosciences, and Teva Pharmaceutical Industries. There are quite a few companies in Tardive Dyskinesia Market, which are striving hard to understand the mechanism to treat dyskinesia and are constantly working towards developing innovative drugs in order to provide accurate test results. Teva pharmaceutical is also conducting clinical trials of deutetrabenazine for tardive dyskinesia that were started by Auspex Pharmaceutical in 2015.

Request For Customization Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-customization/218

Valbenazine to gain the major market share in TD Drugs Market globally

The global tardive dyskinesia drugs market is segmented on the basis of the sub-types, drugs, end user, and geography. On the basis of sub-type, the global market is divided into choreoathetosis, tardive dystonia, blepharospasm, and tardive akathisia. On the basis of drugs, the Global Market is divided into Valbenazine, Tetrabenazine, and others (deutetrabenazine and VMAT2 inhibitor). On the basis of end user, the global market is divided into hospitals, pharmacies, drug stores, and e-commerce.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.